Milton C. Ault III - 28 Mar 2024 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director, 10%+ Owner
Signature
/s/ Milton C. Ault, III
Issuer symbol
ALZN
Transactions as of
28 Mar 2024
Net transactions value
+$2,127
Form type
4
Filing time
01 Apr 2024, 16:30:20 UTC
Previous filing
28 Mar 2024
Next filing
03 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $2,127 +2,000 +0.26% $1.06 770,365 05 Jan 2024 By Ault Lending, LLC F1
holding ALZN Common Stock 166,865 28 Mar 2024 Direct
holding ALZN Common Stock 996,197 28 Mar 2024 By Ault Life Sciences, Inc. F2
holding ALZN Common Stock 5,498 28 Mar 2024 By Ault Life Sciences Fund, LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F2 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.